Galmed Pharmaceuticals Balance Sheet Health
Financial Health criteria checks 6/6
Galmed Pharmaceuticals has a total shareholder equity of $18.4M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $21.0M and $2.5M respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
| Interest coverage ratio | n/a |
| Cash | US$17.14m |
| Equity | US$18.44m |
| Total liabilities | US$2.51m |
| Total assets | US$20.95m |
Recent financial health updates
Recent updates
Financial Position Analysis
Short Term Liabilities: GPH's short term assets ($17.7M) exceed its short term liabilities ($2.5M).
Long Term Liabilities: GPH has no long term liabilities.
Debt to Equity History and Analysis
Debt Level: GPH is debt free.
Reducing Debt: GPH has not had any debt for past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: GPH has sufficient cash runway for more than 3 years based on its current free cash flow.
Forecast Cash Runway: GPH has sufficient cash runway for 2.2 years if free cash flow continues to grow at historical rates of 4.6% each year.